Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor

Digestive and Liver Disease

Volumn 41, Issue 2, 2009, Pages 156-163

  Mancino, A ^a   Mancino, M G ^a   Glaser, S S ^b,c   Alpini, G ^d,e,f   Bolognese, A ^g   Izzo, L ^g   Francis, H ^b   Onori, P ^h   Franchitto, A ^a   Ginanni Corradini, S ^a   Gaudio, E ^a   Alvaro, D ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Division R and E   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Division of Medicine   (United States)

^e Division of Systems Biology   (United States)

^f SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Cholangiocarcinoma; Estrogens; IGF1; Proliferation; VEGF

Indexed keywords

ESTRADIOL; ESTROGEN; FULVESTRANT; SOMATOMEDIN C RECEPTOR; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

AGED; ARTICLE; BILE DUCT CARCINOMA; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; MALE; PROTEIN EXPRESSION; PROTEIN SECRETION; SUPERNATANT; WESTERN BLOTTING;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLANGIOCARCINOMA; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; MALE; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58149214162     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.02.015     Document Type: Article

References (28)

1. Platet N., Cathiard A.M., Gleizes M., and Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 51 (2004) 55-67
2. Hata H., Hamano M., Watanabe J., and Kuramoto H. Role of estrogen and estrogen-related growth factor in the mechanism of hormone dependency of endometrial carcinoma cells. Oncology 55 Suppl 1 (1998) 35-44
3. Ikeda K., and Inoue S. Estrogen receptors and their downstream targets in cancer. Arch Histol Cytol 67 (2004) 435-442
4. Migliaccio A., Castoria G., Di Domenico M., de Falco A., Bilancio A., Lombardi M., et al. Sex steroid hormones act as growth factors. J Steroid Biochem Mol Biol 83 (2002) 31-35
5. Wimalasena J., Meehan D., Dostal R., Foster J.S., Cameron M., and Smith M. Growth factors interact with estradiol and gonadotropins in the regulation of ovarian cancer cell growth and growth factor receptors. Oncol Res 5 (1993) 325-337
6. Ferrara N., and Kerbel R.S. Angiogenesis as a therapeutic target. Nature 438 (2005) 967-974
7. Hyder S.M. The role of steroid hormones on the regulation of vascular endothelial growth factor. Am J Pathol 161 (2002) 345-346
8. Ruohola J.K., Valve E.M., Karkkainen M.J., Joukov V., Alitalo K., and Harkonen P.L. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol 149 (1999) 29-40
9. Nakamura J., Lu Q., Aberdeen G., Albrecht E., and Brodie A. The effect of estrogen on aromatase and vascular endothelial growth factor messenger ribonucleic acid in the normal nonhuman primate mammary gland. J Clin Endocrinol Metab 84 (1999) 1432-1437
10. Khan S.A., Thomas H.C., Davidson B.R., and Taylor-Robinson S.D. Cholangiocarcinoma. Lancet 366 (2005) 1303-1314
11. Blendis L., and Halpern Z. An increasing incidence of cholangiocarcinoma, why?. Gastroenterology 127 (2004) 1008-1009
12. Alvaro D., Barbaro B., Franchitto A., Onori P., Glaser S., Alpini G., et al. Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. Am J Pathol 169 (2006) 877-888
13. Park B.K., Paik Y.H., Park J.Y., Park K.H., Bang S., Park S.W., et al. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma. Am J Clin Oncol 29 (2006) 138-142
14. Tang D., Nagano H., Yamamoto H., Wada H., Nakamura M., Kondo M., et al. Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance. Oncol Rep 15 (2006) 525-532
15. Benckert C., Jonas S., Cramer T., Von Marschall Z., Schafer G., Peters M., et al. Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells. Cancer Res 63 (2003) 1083-1092
16. Kusaka Y., Tokiwa T., and Sato J. Establishment and characterization of a cell line from a human cholangiocellular carcinoma. Res Exp Med (Berl) 188 (1988) 367-375
17. Park J., Tadlock L., Gores G.J., and Patel T. Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line. Hepatology 30 (1999) 1128-1133
18. Kahlert S., Nuedling S., van Eickels M., Vetter H., Meyer R., and Grohe C. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J Biol Chem 275 (2000) 18447-18453
19. Adesanya O.O., Zhou J., Samathanam C., Powell-Braxton L., and Bondy C.A. Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle. Proc Natl Acad Sci USA 96 (1999) 3287-3291
20. Losordo D.W., and Isner J.M. Estrogen and angiogenesis: a review. Arterioscler Thromb Vasc Biol 21 (2001) 6-12
21. Ogasawara S., Yano H., Higaki K., Takayama A., Akiba J., Shiota K., et al. Expression of angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in human biliary tract carcinoma cell lines. Hepatol Res 20 (2001) 97-113
22. Surmacz E. Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor. Oncogene 2 (2003) 6589-6597
23. Diel P., Smolnikar K., and Michna H. The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells. Breast Cancer Res Treat 58 (1999) 87-97
24. Gaudio E., Barbaro B., Alvaro D., Glaser S., Francis H., Ueno Y., et al. Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. Gastroenterology 130 (2006) 1270-1282
25. Gaudio E., Barbaro B., Alvaro D., Glaser S., Francis H., Franchitto A., et al. Administration of r-VEGF-A prevents hepatic artery ligation-induced bile duct damage in bile duct ligated rats. Am J Physiol Gastrointest Liver Physiol 291 (2006) G307-G317
26. Ferrara N. VEGF as a therapeutic target in cancer. Oncology 69 Suppl 3 (2005) 11-16
27. Koos R.D., Kazi A.A., Roberson M.S., and Jones J.M. New insight into the transcriptional regulation of vascular endothelial growth factor expression in the endometrium by estrogen and relaxin. Ann NY Acad Sci 1041 (2005) 233-247
28. Stoner M., Wormke M., Saville B., Samudio I., Qin C., Abdelrahim M., et al. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins. Oncogene 23 (2004) 1052-1063